![Kaley Wilson](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Kaley Wilson
Direktor/Vorstandsmitglied bei
Microbion Corp.
Profil
Kaley Wilson currently works at Microbion Corp., as Director, Quark Venture, Inc., as Director-Business Development & Principal from 2016, and Crohn's & Colitis Canada (Canada), as Director from 2021.
Dr. Wilson also formerly worked at ARTMS, Inc., as Chief Executive Officer from 2018 to 2019 and Sitka Biopharma, Inc., as Chief Executive Officer.
Dr. Wilson received his doctorate degree from the University of British Columbia.
Aktive Positionen von Kaley Wilson
| Unternehmen | Position | Beginn |
|---|---|---|
Microbion Corp.
 Microbion Corp. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage pharmaceutical company | Direktor/Vorstandsmitglied | - |
Quark Venture, Inc.
 Quark Venture, Inc. Investment ManagersFinance Quark Venture Inc invests in companies located globally. The firm targets companies operating in the fields of innovative biotechnology and health sciences. It provides financing in the form of equity. | Private Equity Investor | 01.10.2016 |
Crohn?s & Colitis Canada
 Crohn?s & Colitis Canada Miscellaneous Commercial ServicesCommercial Services Operates as a volunteer based charity that focused on finding the cures for crohn’s disease and ulcerative colitis & improving the lives of children and adults | Direktor/Vorstandsmitglied | 01.05.2021 |
Ehemalige bekannte Positionen von Kaley Wilson
| Unternehmen | Position | Ende |
|---|---|---|
Sitka Biopharma, Inc.
 Sitka Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Develops novel polymer platform technology that improves drug absorption for cancer treatments | Vorstandsvorsitzender | 01.06.2022 |
ARTMS, Inc.
 ARTMS, Inc. BiotechnologyHealth Technology Operates as a biotechnology company | Vorstandsvorsitzender | 10.09.2019 |
Ausbildung von Kaley Wilson
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
4
Beziehungen ersten Grades
6
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 6 |
|---|---|
Microbion Corp.
Microbion Corp. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage pharmaceutical company | Health Technology |
University of British Columbia
 University of British Columbia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Quark Venture, Inc.
Quark Venture, Inc. Investment ManagersFinance Quark Venture Inc invests in companies located globally. The firm targets companies operating in the fields of innovative biotechnology and health sciences. It provides financing in the form of equity. | Finance |
Sitka Biopharma, Inc.
Sitka Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Develops novel polymer platform technology that improves drug absorption for cancer treatments | Health Technology |
ARTMS, Inc.
ARTMS, Inc. BiotechnologyHealth Technology Operates as a biotechnology company | Health Technology |
Crohn?s & Colitis Canada
Crohn?s & Colitis Canada Miscellaneous Commercial ServicesCommercial Services Operates as a volunteer based charity that focused on finding the cures for crohn’s disease and ulcerative colitis & improving the lives of children and adults | Commercial Services |
